Andromeda Shock refers to patients who appear outwardly stable despite experiencing severe internal physiological decline, often due to uncompensated shock. These individuals may initially present with normal vital signs, masking critical organ hypoperfusion and cellular hypoxia.
A key indicator of this hidden shock is an elevated and rising lactate level, reflecting impaired cellular metabolism. Another important diagnostic tool is end-tidal carbon dioxide, or ETCO2. A low ETCO2, particularly below 25 mmHg or even 20 mmHg, in a spontaneously breathing patient can signal profound metabolic acidosis, even if the breathing rate appears normal. This occurs as bicarbonate buffers acid, releasing carbon dioxide for exhalation.
Common causes include sepsis, severe trauma, pancreatitis, and extensive burns. In these conditions, macro-hemodynamic parameters like blood pressure can be maintained by compensatory mechanisms, but microcirculatory dysfunction leads to critical impairment of tissue perfusion.
Early recognition is paramount. Clinical suspicion should be high, especially in patients with subtle changes in mental status, cold or mottled skin, or those who are elderly or on medications like beta-blockers that can blunt typical shock responses. Resuscitation efforts should focus on identifying and treating the underlying cause, managing fluids judiciously, and potentially using vasoactive agents to support perfusion. While maintaining a target mean arterial pressure is important, true improvement requires resolution of microcirculatory dysfunction and normalization of lactate levels.
As far as I can tell, despite talking about the paper widely at conferences, I never included a write up of the original ANDROMEDA-SHOCK trial on First10EM. (Hernández 2019) (There is a massive file of all the topics I want to cover, and would cover if this was a job rather than a hobby. I […]
The post Not so fast with the capillary refill guided resuscitation (ANDROMEDA-SHOCK-2) appeared first on First10EM.
